By using two cell lines, human hepatoma cells (HepG2) and human embryonic kidney cells (HEK293), which express wild-type p53, we found that knockdown of endogenous p53 increased ZIP14 levels and NTBI uptake, but did not change DMT1 levels. This evidence concerns the gene TP53 and hepatocellular carcinoma.